| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/29/2009 | CN101495138A Identification of protective antigenic determinants of porcine reproductive and respiratory syndrome virus (PRRSV) and uses thereof |
| 07/29/2009 | CN101495137A Novel plant virus particles and methods of inactivation thereof |
| 07/29/2009 | CN101495136A Antibody formulation |
| 07/29/2009 | CN101492496A A method for identification, isolation and production of antigens to a specific pathogen |
| 07/29/2009 | CN101491674A Production technique of dual vaccine of chicken new castle disease and infectious bronchitis |
| 07/29/2009 | CN101491673A Triple vaccine of pig transmissible gastroenteritis, pig epidemic diarrhea and pig rotavirus |
| 07/29/2009 | CN101491672A Chicken new castle disease-bird influenza dual oil-emulsion inactivated vaccine and preparation method thereof |
| 07/29/2009 | CN101491671A Cross-protection vaccine and building method thereof |
| 07/29/2009 | CN100520408C Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors |
| 07/29/2009 | CN100519757C Tiacumicin production |
| 07/29/2009 | CN100519749C Agonist anti-TRK-C monoclonal antibodies |
| 07/29/2009 | CN100519584C Antibodies against fibroblast growth factor 23 |
| 07/29/2009 | CN100518824C Recombinant His-IT-B7-H11gV tumor vaccine, and its preparing method |
| 07/29/2009 | CN100518823C Hapten-carrier conjugates and uses thereof |
| 07/29/2009 | CN100518822C Use of short-small-rod like bacillus for preparing pig's infections pleuropneumonia biological preparation |
| 07/29/2009 | CN100518821C Mosaic vaccine of Ag85B and ESAT-6 |
| 07/29/2009 | CN100518814C Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into biological environmentat from polymer matrix |
| 07/29/2009 | CN100518739C A retroviral immunotherapy |
| 07/28/2009 | US7566776 Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics |
| 07/28/2009 | US7566770 Humanized collagen antibodies and related methods |
| 07/28/2009 | US7566767 Synthetic peptides and methods of use for autoimmune disease therapies |
| 07/28/2009 | US7566568 Method for generating highly active human dendritic cells from peripheral blood mononuclear cells |
| 07/28/2009 | US7566562 Culturing circular ssDNA viruses for the production of vaccines |
| 07/28/2009 | US7566546 Modulators of angiogenesis and tumorigenesis |
| 07/28/2009 | US7566543 denaturing the protein in such test set with guanidine thiocyanate or one or more chaotropic agents so as to enhance antibody reactivity towards aberrant protein while antibody reactivity towards a normal form of the protein is reduced or unchanged; reducing the risk of scoring a false-positive test |
| 07/28/2009 | US7566539 Anti-CCR2 antibodies and methods of use therefor |
| 07/28/2009 | US7566459 Which have functional lspA gene deletions; vaccines |
| 07/28/2009 | US7566458 Influenza hemagglutinin and neuraminidase variants |
| 07/28/2009 | US7566457 Proteins for use as vaccine to prevent dengue virus infection; immunotherapy; high serotype-specificity to be used in humans |
| 07/28/2009 | US7566456 Allergen vaccine proteins for the treatment and prevention of allergic diseases |
| 07/28/2009 | US7566455 Vaccine with a component of a ubiquitin-ligase (E3) enzyme; regulation of gene expression, regulation of the cell-cycle, modification of cell surface receptors, biogenesis of ribosomes, and DNA repair |
| 07/28/2009 | US7566454 Immunization against influenza by administering codon-optimized forms of nucleic acids encoding influenza polypeptides such as influenza hemagglutinin (HA), neuraminidase (NA) |
| 07/28/2009 | US7566453 Methods for treating melanomas |
| 07/28/2009 | US7566452 Treating cancer using antagonists to the endothelin B receptor (ETB) or inactive mimic forms of endothelin-1; melanoma |
| 07/28/2009 | US7566451 Human immunodeficiency virus-neutralizing human antibodies with improved breadth and potency |
| 07/28/2009 | US7566450 Using cc-chemokine receptor 2 (CCR2) specific immunoglobulins for use in treatment and prevention of skin disorders |
| 07/28/2009 | US7566449 Method and composition for inhibition of angiogenesis using antagonists based on MMP-9 and β1 integrins |
| 07/28/2009 | CA2148369C Actinobacillus pleuropneumoniae outer membrane lipoprotein a and uses thereof |
| 07/23/2009 | WO2009092113A2 Methods and compositions for the delivery of vaccines to disrupted epithelium |
| 07/23/2009 | WO2009092052A2 Methods and compositions for treating polyps |
| 07/23/2009 | WO2009092049A1 Improved anti-trkb antibodies |
| 07/23/2009 | WO2009092038A1 Influenza dna vaccination and methods of use thereof |
| 07/23/2009 | WO2009092011A1 Cysteine engineered antibodies for site-specific conjugation |
| 07/23/2009 | WO2009091905A1 Methods of treating bone-loss disorders using a gm-csf antagonist |
| 07/23/2009 | WO2009091889A1 Treatment of skin disorders with egfr inhibitors |
| 07/23/2009 | WO2009091810A1 Methods for inhibiting angiogenesis using egfl8 antagonists |
| 07/23/2009 | WO2009091601A1 Methods for manipulating phagocytosis mediated by cd47 |
| 07/23/2009 | WO2009091542A2 Antibodies to bufadienolides prevent inhbition of na/katpase and prolong survival in shock |
| 07/23/2009 | WO2009091341A1 Novel peptides and protein and uses thereof |
| 07/23/2009 | WO2009090650A2 Vaccine for alzheimer's disease |
| 07/23/2009 | WO2009090594A2 Alphavirus based vectors |
| 07/23/2009 | WO2009090512A1 A truncated form of the hiv p17 protein |
| 07/23/2009 | WO2009090461A1 Heat treated bacterins, and emulsion vaccines prepared from such heat treated bacterins |
| 07/23/2009 | WO2009090330A2 Use of protein 8c2 for in vitro diagnosis of mycoplasma pneumoniae infections |
| 07/23/2009 | WO2009090268A1 Peptide mimetics |
| 07/23/2009 | WO2009090189A1 Powdered protein compositions and methods of making same |
| 07/23/2009 | WO2009090175A1 Vaccine comprising a ribosomal protein extract (rpe) and optionally a th1-promoting adjuvant |
| 07/23/2009 | WO2009090093A1 Bacterial ghost (bg) production process using betapropiolactone (blp) for final inactivation |
| 07/23/2009 | WO2009090032A1 Afucosylated antibodies against ccr5 and their use |
| 07/23/2009 | WO2009089858A1 COMBINATION OF AN ANTI-EDb FIBRONECTIN ANTIBODY-IL-2 FUSION PROTEIN, AND A MOLECULE BINDING TO B CELLS, B CELL PROGENITORS AND/OR THEIR CANCEROUS COUNTERPART |
| 07/23/2009 | WO2009089605A1 Recombinant viral vectors and vaccine composition for leishmaniasis |
| 07/23/2009 | WO2009089568A1 Immunomodulating compositions and uses therefor |
| 07/23/2009 | WO2009073648A3 Compositions and methods for regulating entamoeba histolytica function |
| 07/23/2009 | WO2009073575A3 Methods for treating induced cellular proliferative disorders |
| 07/23/2009 | WO2009072767A3 A powerful vaccine composition comprising a lipopeptide and poly i:c as an adjuvant |
| 07/23/2009 | WO2009067020A4 Bioactive copepod-compositions, processes for the production thereof, and use thereof to prevent or treat hosts infested by phylogenetically similar ectoparasites |
| 07/23/2009 | WO2009065032A8 Antibody production elicited by a dna vaccine delivered by electroporation |
| 07/23/2009 | WO2009058734A4 Compounds exhibiting glucagon antagonist and glp-1 agonist activity |
| 07/23/2009 | WO2009058492A3 Fc variants with altered binding to fcrn |
| 07/23/2009 | WO2009056965A3 A multicomponent or monocomponent vaccine to be used against chagas disease |
| 07/23/2009 | WO2009052379A3 Improved antitumoral treatments |
| 07/23/2009 | WO2009052081A4 Antibodies that bind il-4 and/or il-13 and their uses |
| 07/23/2009 | WO2009051837A3 Vaccine nanotechnology |
| 07/23/2009 | WO2009042202A3 Formulations for preservation of rota virus |
| 07/23/2009 | WO2009037262A3 Method of preventing early lawsonia intracellularis infections |
| 07/23/2009 | WO2009011912A8 A composition for treating hiv comprising virus-like particles |
| 07/23/2009 | WO2008136774A8 Antibodies binding to an intracellular prl-1 or prl-3 polypeptide |
| 07/23/2009 | WO2008136736A8 Immunoregulatory structures from normally occurring proteins |
| 07/23/2009 | WO2008133684A8 Antibodies that bind both il-17a and il-17f and methods of using the same |
| 07/23/2009 | WO2008127179A8 Fusion protein vaccine |
| 07/23/2009 | WO2008086386A8 Adenoviral vector-based malaria vaccines |
| 07/23/2009 | WO2008068631A8 Vaccines including antigen from four strains of influenza virus |
| 07/23/2009 | WO2008057396A8 Canine lyme disease vaccine |
| 07/23/2009 | WO2007143701A8 Monoclonal antibodies that potently neutralize hepatitis c virus (hcv) of diverse genotypes |
| 07/23/2009 | WO2007134166A9 Real-time detection of influenza virus |
| 07/23/2009 | WO2007116409A8 Improved vaccines comprising multimeric hsp60 peptide carriers |
| 07/23/2009 | WO2007104000A8 Hybrid protein that converts arachidonic acid into prostacyclin |
| 07/23/2009 | WO2007101262A8 Attenuated francisella bacteria |
| 07/23/2009 | WO2007101227A8 Identification and use of novopeptides for the treatment of cancer |
| 07/23/2009 | WO2007092939A8 Antigenic gm-csf peptides and antibodies to gm-csf |
| 07/23/2009 | WO2007090294A8 Anti-bfa4 monoclonal antibodies and for cancer diagnostics and treatment |
| 07/23/2009 | US20090187996 Ion Channel |
| 07/23/2009 | US20090187007 Using estrogen receptor specific immunoglobulins to treat cell proliferative disorders of mammary glands |
| 07/23/2009 | US20090186871 Tyrosine kinase inhibitors |
| 07/23/2009 | US20090186820 Streptococcus pyogenes polypeptides and corresponding dna fragments |
| 07/23/2009 | US20090186409 Compositions and methods for the diagnosis and treatment of tumor |
| 07/23/2009 | US20090186363 Compositions and methods for the diagnosis and treatment of tumor |
| 07/23/2009 | US20090186338 Oligonucleotides originating from sequences coding for the surface component of ptlv envelope proteins and their uses |
| 07/23/2009 | US20090186337 N protein of a virus of the paramyxoviridae family-protein of interest fusion proteins |
| 07/23/2009 | US20090186099 Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system |